People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PolyPid Ltd. | — | Biotechnology | Series B | $125.4M | $126.2M | 2024 |
| Can-Fite BioPharma Ltd. | — | Pharmaceuticals | Series A | $82.2M | $160.3M | 2014 |
| Aulos Bioscience, Inc. | — | Biotechnology | Series A | $20.0M | $41.1M | 2020 |
Yechezkel Barenholz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yechezkel Barenholz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Seth Harrison | 1 | 19 |
| Michael Ehlers | 1 | 6 |
| Robert B. Stein | 1 | 5 |
| Yaacov Goldman | 1 | 3 |
| Joseph Yanchik | 1 | 3 |
| Rajesh Chopra | 1 | 2 |
| Anna Batarina | 1 | 2 |
| Nir Dror | 1 | 2 |
| Yanay Ofran | 1 | 2 |
| Itzhak Krinsky | 1 | 2 |
| Pnina Fishman | 1 | 1 |
| Amir Weisberg | 1 | 1 |
| Eitan Kyiet | 1 | 1 |
| Dikla Czaczkes Akselbrad | 1 | 1 |
| Noam Emanuel | 1 | 1 |
| Guy Regev | 1 | 1 |
| Yitzchak Jacobovitz | 1 | 1 |
| Barak Singer | 1 | 1 |
| Abraham Sartini | 1 | 1 |
| Ori Warshavsky | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.